The Hypertension Toolkit: a mobile health program to help people manage high blood pressure
Official title: The Hypertension Toolkit: an adaptive mobile health blood pressure intervention
Funded at University of Pittsburgh at Pittsburgh · NIH-11281998 · Data updated 2026-11-12
A new mobile health program helps people with high blood pressure manage their condition, using home blood pressure monitoring, education, and personalized coaching.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project start | July 13, 2026 |
| Project end | June 30, 2027 |
| Funding year | 2026 |
| Award (this year) | $1,019,556 |
| NIH project number | 1R61HL183037-01 |
| Project ID | NIH-11281998 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults with hypertension who receive care at participating community clinics and have access to a mobile device.
✕Less likely to help
Patients without access to remote monitoring or smartphone-assisted coaching may not benefit as much.
What this research studies
This project tests a multilevel toolkit delivered through mobile tools and clinic support to help people in primary care manage hypertension. Participants use home blood pressure monitoring and receive a self-management workbook plus a virtual coach that guides lifestyle changes and treatment adherence. Depending on response, some participants may get additional digital support or pharmacist-led therapy adjustments. The trial follows a SMART design to tailor follow-up actions based on how blood pressure responds over time.
Why it matters
Potential benefit: If successful, the toolkit could lead to better blood pressure control and fewer heart-related complications.
How similar studies have gone: Previous studies have shown digital coaching and home BP monitoring can improve BP control in diverse populations.
Where this research is happening
-
University of Pittsburgh at Pittsburgh
Pittsburgh, United States Active
Researchers
- Principal investigator: Magnani, Jared W. — University of Pittsburgh at Pittsburgh
- Study coordinator: Magnani, Jared W.
Related research
Other NIH-funded projects on the same topics.
-
PFAS in drinking water and blood pressure in adults and kids
This project looks at how chemical PFAS in drinking water may be linked to high blood pressure in both adults and children.
-
Hypertension, Blood Pressure Targets, and Alzheimer’s Risk and Disparities in US Veterans
This project looks at how blood pressure control and its targets relate to Alzheimer's and related dementia risk in diverse U.S. veterans.
-
Understanding how clinician decisions affect hypertension control across different groups
Doctors’ adherence to hypertension guidelines varies and this study looks at how that impacts blood pressure control among different races and regions.
-
Gestational hypertension and preeclampsia: better blood pressure targets before delivery
This study tests whether keeping blood pressure under 140/90 mmHg (instead of 160/110) during pregnancy with high blood pressure improves outcomes for mothers and babies.
-
How integrase HIV drugs might affect blood pressure through kidney function and weight
This project looks at whether a common class of HIV drugs (INSTIs) changes blood pressure in people with HIV and whether kidney function or weight explain those changes.
-
Phone-based mindfulness program to lower blood pressure in Black women with hypertension
This project offers a phone-delivered mindfulness and cognitive skills program to see if it lowers blood pressure in Black women with high blood pressure.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.